Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

Josje J. Otten; Hester E. Elzinga; Rik J. L. van der Lans; Wytske J. Fokkens; Sietze Reitsma; PolyREG Consortium

doi:10.1111/all.16496

Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

Josje J. Otten, Hester E. Elzinga, Rik J. L. van der Lans, Wytske J. Fokkens, Sietze Reitsma^*, PolyREG Consortium

^*Corresponding author for this work

Amsterdam UMC - University of Amsterdam

Research output: Contribution to journal › Comment/Letter to the editor › Academic

7 Downloads (Pure)

Original language	English
Pages (from-to)	1166-1168
Number of pages	3
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	80
Issue number	4
Early online date	2025
DOIs	https://doi.org/10.1111/all.16496
Publication status	Published - Apr 2025

Keywords

chronic rhinosinusitis
control
dupilumab
nasal polyps
remission

Access to Document

10.1111/all.16496

Almost-half-of-the-dupilumab-treated-patients-with-severe-chronic-rhinosinusitis-with-nasal-polyps-achieve-remission-in-.pdfFinal published version, 166 KB

Cite this

@article{d005bea07bd74f9eadec796dfcad194e,

title = "Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year",

keywords = "chronic rhinosinusitis, control, dupilumab, nasal polyps, remission",

author = "Otten, \{Josje J.\} and Elzinga, \{Hester E.\} and \{van der Lans\}, \{Rik J. L.\} and Fokkens, \{Wytske J.\} and Sietze Reitsma and \{PolyREG Consortium\} and Cornet, \{M. E.\} and Rinia, \{A. B.\} and Kleiss, \{I. J.\} and I. Krebbers and Adriaensen, \{G. F. J. P. M.\} and Benoist, \{L. B. L.\} and Hoven, \{D. R.\} and Timmer, \{F. C. A.\}",

year = "2025",

month = apr,

doi = "10.1111/all.16496",

language = "English",

volume = "80",

pages = "1166--1168",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley Blackwell",

number = "4",

}

Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year. / Otten, Josje J.; Elzinga, Hester E.; van der Lans, Rik J. L. et al.
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 80, No. 4, 04.2025, p. 1166-1168.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

AU - Otten, Josje J.

AU - Elzinga, Hester E.

AU - van der Lans, Rik J. L.

AU - Fokkens, Wytske J.

AU - Reitsma, Sietze

AU - PolyREG Consortium

AU - Cornet, M. E.

AU - Rinia, A. B.

AU - Kleiss, I. J.

AU - Krebbers, I.

AU - Adriaensen, G. F. J. P. M.

AU - Benoist, L. B. L.

AU - Hoven, D. R.

AU - Timmer, F. C. A.

PY - 2025/4

Y1 - 2025/4

KW - chronic rhinosinusitis

KW - control

KW - dupilumab

KW - nasal polyps

KW - remission

UR - http://www.scopus.com/inward/record.url?scp=85217540428&partnerID=8YFLogxK

U2 - 10.1111/all.16496

DO - 10.1111/all.16496

M3 - Comment/Letter to the editor

C2 - 39912310

SN - 0105-4538

VL - 80

SP - 1166

EP - 1168

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 4

ER -

Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year

Keywords

Access to Document

Other files and links

Cite this